Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Arbor Biotechnologies in Cambridge, MA seeks an in vivo pharmacology scientist to drive rodent studies from dosing through tissue collection to molecular readouts. You will run studies, monitor animals, collect samples, and generate data feeding preclinical decisions.
Required: a Bachelor's in pharmacology/biology/neuroscience or related field with 3+ years in industry or a Master's with 1+ year; hands-on in vivo rodent work (IV/retro-orbital); molecular assays (qPCR/ddPCR, RT-qPCR, ELISA,
Who We Are. Arbor Biotechnologies, a clinical stage, next-generation gene editing company based in Cambridge, MA, is advancing a portfolio of first-in-class genomic medicines addressing serious diseases for which there are no existing functional cures, with a CNS pipeline initially prioritizing multiple ALS targets and a co-developed, clinical program, ABO-101, for the treatment of primary hyperoxaluria type 1. The company’s unique breadth of gene editing technologies goes beyond the limitations of early editing approaches to unlock access to new gene targets and expand the therapeutic reach of genomic medicines. For more information, please visit: arbor.bio.
Who We Are. Arbor Biotechnologies, a clinical stage, next-generation gene editing company based in Cambridge, MA, is advancing a portfolio of first-in-class genomic medicines addressing serious diseases for which there are no existing functional cures, with a CNS pipeline initially prioritizing multiple ALS targets and a co-developed, clinical program, ABO-101, for the treatment of primary hyperoxaluria type 1. The company’s unique breadth of gene editing technologies goes beyond the limitations of early editing approaches to unlock access to new gene targets and expand the therapeutic reach of genomic medicines. For more information, please visit: arbor.bio.
Who thrives here.
You're driven by purpose and curious by nature. You take ownership, speak up, and stay steady when things get hard. You'd rather the team win than get the credit. If that sounds like you, keep reading.
Our gene editing programs for neurodegenerative diseases can only advance if in vivo studies show that an editor works in a living animal. This role carries those studies from dosing through tissue collection to the molecular readout. The data you generate feeds the preclinical and IND-enabling work that decides whether a program moves forward.
This role reports to the Senior Scientist, In Vivo Pharmacology. It is on-site in Cambridge, typically 4–5 days per week.
The anticipated base salary range for this role is $85,000–$95,000. Actual pay depends on relevant experience, skills, education, internal equity, and other job-related factors.
Every employee is eligible for a bonus and new hire equity. We pay about 90% of medical, dental, and vision premiums and fund the full deductible on our HSA plan. You'll also get 12 weeks of parental leave at full pay, paid parking or transit, a 401(k) match, and discretionary time off.
Arbor is an equal opportunity employer. We're committed to a hiring process and a workplace free of bias and discrimination, and we welcome candidates of every background.